Portfolio pick:

Granules India NSE -1.17 % has announced that Granules Pharmaceutical, its wholly-owned foreign subsidiary located at Virginia, USA, has cleared a pre-approved inspection for three applications filed in that facility. This is good news for the company. As it plays on the defensive side of the market, it is a good stock to have in your portfolio. On technical grounds, Granules India, after a long consolidation on weekly charts, has given a horizontal breakup. Volumes have also marginally increased. Both RSI and MACD are in favour and above 400. It will make a good up move. The target price level for Granules India will be Rs 450 and one should keep a stop loss at Rs 350.

Trade with Raj

#granules #granulesindia #pharmaceuticalindustry #tradewithraj #brainmassinvestors #buyandhold #portfoliostock #longterminvesting

#GRANULES corrected from high of 395 to 358 which was close to our SL 350, and it was a good opportunity to average it. We are holding for TGT 450 on short terms.

#granules CMP 308 took support 298 next resistance 316 add more if it holds and 15min/hr chart looks good

#granules 308->315

#granules 308->318.30

#granules 308->320

#granules 308->323

#granules 308->330

#Our favourite stock #granules is bullish on the daily chart cmp 345 with good support at 325 can see level 360 and beyond

My eyes on #granules 319, looks set up for good gain. Also when I keep eyes on something it moves like there is no tomorrow 😎

#granules daily chart is mildly bullish CMP 351